LABOMAR

MID SMALL CAP FORUM-EUROPE

Madrid, November 3rd, 2022

TODAY SPEAKERS

WALTER BERTIN

CLAUDIO DE NADAI

Founder & CEO

IR & Board Director

CLAUDIO CRESPAN

CFO

FRANCESCO DA RIVA

Head of Sales

Founded Labomar in 1998 from the "Farmacia Bertin"

Member of Assindustria Veneto Centro since 2012

Graduated in pharmaceutical science and completed a Master degree in Lean Mangement

Consultant for Labomar since 2007 on financial strategy and Board Member since 2018, he led the asset deal of ImportFab and Welcare

After 13 yars as CFO and General Manager of an Italian SME and a past entrepreneurial experience in agri-food, he founded BModel (corporate finance boutique)

Joined Labomar Group in 2021 and appointed as CFO

15 years in extensive previous experience as CFO and M&A in international structured Companies, previous experience in a big4 Audit Firm.

Vice President of ANDAF North East (CFO association)

Significant experience in Labomar, first as Head of Foreign Sales and since the beginning of 2020 as Head of Sales and Commercial Networks

Extensive previous experience as Senior Consultant in Strategy and Business Planning

Education: MiMAC 1 (SDA Bocconi School of Management) EMBA 16 (CUOA Business School)

2

AGENDA

1

2

3

Heritage,

Vision & Mission,

Sustainability

Labomar

Stand Alone

Labomar Business Model Evolution

4

1H 2022 Results,

3Q 2022 Revenues

and 2022 Guidance

5

Focus Single

Controlled Companies

3

AGENDA

1

2

3

Heritage,

Vision & Mission,

Sustainability

Labomar

Stand Alone

Labomar Business

Model Evolution

4

1H 2022 Results,

3Q 2022 Revenues

and 2022 Guidance

5

Focus Single

Controlled Companies

4

HERITAGE

Foundation of

LABOMAR RESEARCH,

the R&D Branch

of Labomar;

Fondo Italiano

the company

starts building

Labomar starts

d'Investimento invests

Since 2016

its reserach-driven

in Labomar's equity

building a

Start of the Lean

DNA

committed qualified

Transformation

management team

process

1998

2004

2011

2015

2018

November, acquisition of Importfab, Canada-basedPharma

CMO

Equity investment (5%) in Project Zero srl, devolping vertical farming techniques for vegetal extracts

Establishment of Herbae srl (now Labomar Next srl)

2020

2021

July

Acquisition of the majority of Welcare Research srl, Italian company specialized in wound healing medical devices

September

Set up of Labovar srl, a commercial company that will sell online

in the Chinese market

Acquisition of the 17,6% of Labiotre srl. With this partecipation, Labomar owns 48,8% of Labiotre srl.

November

Labomar owns 100% of Labiotre srl

2003 2008

Labomar begins its transformation from pharmaceutical lab to industrial manufacturing company

Foundation of LABOMAR from the pharmacy of Dr. Bertin

2012 2016

Foundation of Labiotre

s.r.l., to guarantee the

highest possible quality

of raw materials

Roll-off of the

Attainment of the

brand-new,

GMP and ISO9001

pharmagrade

certifications

standard L3 plant

2019

Juanuary

Dr Bertin buys back minorities and owns 100% of Labomar

August

Statue Change

October

Listing on Milan stock exchange

December

Labomar exercises call option andacquires an additional 7%

of Welcare Research srl, increasing its stake to 70%

COMING SOON

L6 new headquarter and production plant construction

Source: Management

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Labomar S.p.A. published this content on 28 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 November 2022 09:59:08 UTC.